Surviving Sepsis Campaign: International Guideline for Management of Sepsis and Septic Shock (2016): progress and comments

doi:10.3877/cma.j.issn.2096-1537.2017.01.006

Abstract

Abstract:

Sepsis remains a big challenge in clinic which promote clinicians to continue explore its diagnosis and management. Recently, Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) updated the Surviving Sepsis Campaign (SSC) which would change the strategy of sepsis to some extent. Understanding the key point of the new guideline is crucial in sepsis management.

Key words: Sepsis, Intensive care, Guidebooks, Shock

Jianfeng Xie, Haibo Qiu. Surviving Sepsis Campaign: International Guideline for Management of Sepsis and Septic Shock (2016): progress and comments[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2017, 03(01): 18-25.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://icu.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2096-1537.2017.01.006

https://icu.cma-cmc.com.cn/EN/Y2017/V03/I01/18

References 31

[1]	Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock[J]. Crit Care Med, 2004, 32(3): 858–873.
[2]	Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016[J]. Intensive Care Med, 2017 Jan 18. [Epub ahead of print]
[3]	Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016[J]. Crit Care Med, 2017 Jan 17. [Epub ahead of print]
[4]	Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801–810.
[5]	Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 775–787.
[6]	Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic Shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 762–774.
[7]	Peake SL, Delaney A, Bailey M, et al. Goal-directed resuscitation for patients with early septic shock[J]. N Engl J Med, 2014, 371(16): 1496–1506.
[8]	Yealy DM, Kellum JA, Huang DT, et al. A randomized trial of protocol- based care for early septic shock[J]. N Engl J Med, 2014, 370(18): 1683–1693.
[9]	Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock[J]. N Engl J Med, 2015, 372(14): 1301–1311
[10]	Rivers E, Nguyen B, Havstad S, et al. Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock[J]. N Engl J Med, 2001, 345(19): 1368–1377.
[11]	Levy MM, Rhodes A, Phillips GS, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study[J]. Crit Care Med, 2015, 43(1): 3–12.
[12]	潘纯, 邱海波. 改善脓毒症治疗指南依从性: 影响因素与应对措施[J/OL]. 中华重症医学电子杂志, 2016, 2(1): 32–35.
[13]	Vincent JL, Brealey D, Libert N, et al. Rapid diagnosis of infections in the critically ill team: rapid diagnosis of infection in the critically ill, a multicenter study of molecular detection in bloodstream infections, pneumonia, and sterile site infections[J]. Crit Care Med, 2015, 43(11): 2283–2291.
[14]	Sawyer RG, Claridge JA, Nathens AB, et al. Trial of short-course antimicrobial therapy for intraabdominal infection[J]. N Engl J Med, 2015, 372(21): 1996–2005.
[15]	Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock[J]. N Engl J Med, 2014, 370(15): 1412–1421.
[16]	Xu JY, Chen QH, Xie JF, et al. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials[J]. Crit Care, 2014, 18(6): 702.
[17]	Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults[J]. JAMA, 2012, 308(15): 1566–1572.
[18]	Young P, Bailey M, Beasley R, et al. Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial[J]. JAMA, 2015, 314(16): 1701–1710.
[19]	Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial[J]. JAMA, 2009, 301(23): 2445–2452.
[20]	Klein DJ, Foster D, Schorr CA, et al. The EUPHRATES trial (Evaluating the use of polymyxin B hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock): study protocol for a randomized controlled trial[J]. Trials, 2014, 15: 218.
[21]	Zarychanski R, Abou-Setta AM, Kanji S, et al. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis[J]. Crit Care Med, 2015, 43(3): 511–518.
[22]	Guérin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome[J]. N Engl J Med, 2013, 368(23): 2159–2168.
[23]	Beitler JR, Shaefi S, Montesi SB, et al. Prone positioning reduces mortality from acute respiratory distress syndrome in the low tidal volume era: a meta-analysis[J]. Intensive Care Med, 2014, 40(3): 332–341.
[24]	Futier E, Constantin JM, Paugam-Burtz C, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery[J]. N Engl J Med, 2013, 369(5): 428–437.
[25]	Lonardo NW, Mone MC, Nirula R, et al. Propofol is associated with favorable outcomes compared with benzodiazepines in ventilated intensive care unit patients[J]. Am J Respir Crit Care Med, 2014, 189(11): 1383–1394.
[26]	Fraser GL, Devlin JW, Worby CP, et al. Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials[J]. Crit Care Med, 2013, 41(9 Suppl 1): S30–S38.
[27]	Reade MC, Eastwood GM, Bellomo R, et al. Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial[J]. JAMA, 2016, 315(14): 1460–1468.
[28]	Gaudry S, Hajage D, Schortgen F, et al. AKIKI Study Group: Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit[J]. N Engl J Med, 2016, 375(2): 122–133.
[29]	Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial[J]. JAMA, 2016, 315(20): 2190–2199.
[30]	Junqueira DR, Perini E, Penholati RR, et al. Unfractionated heparin versus low molecular weight heparin for avoiding heparininduced thrombocytopenia in postoperative patients[J]. Cochrane Database Syst Rev, 2012, (9): CD007557.
[31]	Alhazzani W, Alenezi F, Jaeschke RZ, et al. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis[J]. Crit Care Med, 2013; 41(3): 693–705.

Please choose a citation manager

Content to export